Results 131 to 139 of about 105,823 (139)

Assessing Causality Between Endocrine, Nutritional, and Metabolic Disease and Pulmonary Tuberculosis: A Mendelian Randomization Study

open access: yesHealth Science Reports, Volume 8, Issue 6, June 2025.
Abstract Background and Aims Observational studies frequently report co‐occurrence between endocrine, nutritional, and metabolic disease (ENMD) and pulmonary tuberculosis (PTB). However, the causal properties between them remain poorly defined. Our aim in this study was to investigate the causal effect of ENMD on PTB using Mendelian randomization ...
Yan Gao   +5 more
wiley   +1 more source

Impact of Angiotensin‐Converting Enzyme Inhibitor on Coronary Artery Calcification Evaluated by Intravascular Ultrasound: A Retrospective Cohort Study

open access: yesHealth Science Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background and Aims Coronary artery calcification (CAC) is a predictor of poor prognosis after percutaneous coronary intervention (PCI), and its treatment depends on calcification severity assessed by intravascular imaging such as intravascular ultrasound (IVUS).
Daisuke Kanda   +8 more
wiley   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Enolase and 16.5‐kDa Tegument‐Associated Protein in Fasciola hepatica Extracellular Vesicles: Clues to Their Role in Pathogenesis

open access: yesJournal of Extracellular Biology, Volume 4, Issue 6, June 2025.
Recombinant enolase and 16.5 tegumentary proteins from F. hepatica EVs may influence the progression of fibrosis, altering cell growth, proteomic profiles, and EVs secretion in macrophages, hepatic stellate cells (HSCs) and hepatocytes. r‐Fhenolase reduced fibrosis markers in HSCs and exhibited anti‐inflammatory properties in macrophages, and r‐Fh16 ...
Aránzazu González‐Arce   +4 more
wiley   +1 more source

Proteomics of Urinary Extracellular Vesicles Highlight the Involvement of Vitronectin and the Fibrinolytic and TNF Pathways as Mechanisms Underlying Renal Fibrosis in Kidney Transplant Patients

open access: yesJournal of Extracellular Biology, Volume 4, Issue 6, June 2025.
ABSTRACT Vitronectin (VTN) is a potential non‐invasive biomarker for renal fibrosis, originally described in urinary extracellular vesicles (uEV) from kidney transplant patients (KTx). However, VTN's specific role in renal fibrosis is unclear, as it is involved in various physiological processes.
Marta Clos‐Sansalvador   +9 more
wiley   +1 more source

Consensus Statement on Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL‐TSPGHAN Expert Committee

open access: yesJGH Open, Volume 9, Issue 6, June 2025.
ABSTRACT Background and Objective Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most prevalent chronic liver condition in children and adolescents, driven by the global rise in pediatric obesity. In this consensus statement by the Taiwan Association for the Study of the Liver (TASL) and the Taiwan Society of Pediatric ...
Yu‐Cheng Lin   +10 more
wiley   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy